These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 18400630

  • 1. Increased lipoprotein(a) in metabolic syndrome: is it a contributing factor to premature atherosclerosis?
    Bozbaş H, Yildirir A, Pirat B, Eroğlu S, Korkmaz ME, Atar I, Ulus T, Aydinalp A, Ozin B, Müderrisoğlu H.
    Anadolu Kardiyol Derg; 2008 Apr; 8(2):111-5. PubMed ID: 18400630
    [Abstract] [Full Text] [Related]

  • 2. Prevalence and correlates of metabolic syndrome (MS) in older adults.
    Cankurtaran M, Halil M, Yavuz BB, Dagli N, Oyan B, Ariogul S.
    Arch Gerontol Geriatr; 2006 Apr; 42(1):35-45. PubMed ID: 16046242
    [Abstract] [Full Text] [Related]

  • 3. Markers of inflammation and prevalence of vascular disease in patients with metabolic syndrome.
    Novo G, Corrado E, Muratori I, Tantillo R, Bellia A, Galluzzo A, Vitale G, Novo S.
    Int Angiol; 2007 Dec; 26(4):312-7. PubMed ID: 18091698
    [Abstract] [Full Text] [Related]

  • 4. Serum uric acid is a determinant of metabolic syndrome in a population-based study.
    Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Sari I, Yazici M, Keleş I.
    Am J Hypertens; 2006 Oct; 19(10):1055-62. PubMed ID: 17027827
    [Abstract] [Full Text] [Related]

  • 5. Predictors of coronary artery disease in the Lebanese population.
    Abchee A, Puzantian H, Azar ST, Shbaklo H, Nasrallah A, Sawaya FJ, Alam S, Zalloua PA.
    Thromb Res; 2006 Oct; 117(6):631-7. PubMed ID: 15985286
    [Abstract] [Full Text] [Related]

  • 6. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.
    Habib SS.
    J Ayub Med Coll Abbottabad; 2008 Oct; 20(2):3-6. PubMed ID: 19385446
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. C-reactive protein and metabolic syndrome in women with previous gestational diabetes.
    Di Cianni G, Lencioni C, Volpe L, Ghio A, Cuccuru I, Pellegrini G, Benzi L, Miccoli R, Del Prato S.
    Diabetes Metab Res Rev; 2007 Feb; 23(2):135-40. PubMed ID: 16770838
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: a case-control study.
    Balogh E, Bereczky Z, Katona E, Koszegi Z, Edes I, Muszbek L, Czuriga I.
    Thromb Res; 2012 Feb; 129(2):133-8. PubMed ID: 21803402
    [Abstract] [Full Text] [Related]

  • 12. Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study).
    Brodov Y, Behar S, Boyko V, Chouraqui P.
    Am J Cardiol; 2010 Dec 15; 106(12):1717-20. PubMed ID: 21126615
    [Abstract] [Full Text] [Related]

  • 13. Metabolic syndrome: stronger association with coronary artery disease in young men in comparison with higher prevalence in young women.
    Sadeghian S, Darvish S, Salimi S, Esfehani FA, Fallah N, Mahmoodian M, Salarifar M, Karimi A.
    Coron Artery Dis; 2007 May 15; 18(3):163-8. PubMed ID: 17429288
    [Abstract] [Full Text] [Related]

  • 14. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH, Hong J, Lü AK, Chen Y, Shen WF, Li XY, Ning G.
    Chin Med J (Engl); 2008 Dec 20; 121(24):2509-16. PubMed ID: 19187587
    [Abstract] [Full Text] [Related]

  • 15. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study.
    Martínez MA, Puig JG, Mora M, Aragón R, O'Dogherty P, Antón JL, Sánchez-Villares T, Rubio JM, Rosado J, Torres R, Marcos J, Pallardo LF, Banegas JR, MAPA (Monitorización Ambulatoria de la Presión Arterial) Working Group.
    Metabolism; 2008 Sep 20; 57(9):1232-40. PubMed ID: 18702949
    [Abstract] [Full Text] [Related]

  • 16. Relevance of post-methionine homocysteine and lipoprotein (a) in evaluating the cardiovascular risk in young CAD patients.
    Marcucci R, Brunelli T, Fedi S, Pepe G, Giusti B, Gori AM, Prisco D, Falai M, Margheri M, Abbate R, Gensini GF.
    Eur J Clin Invest; 2005 Jan 20; 35(1):1-7. PubMed ID: 15638812
    [Abstract] [Full Text] [Related]

  • 17. [C-reactive protein and homocysteine as risk factors of atherosclerosis].
    Jarosz A, Nowicka G.
    Przegl Lek; 2008 Jan 20; 65(6):268-72. PubMed ID: 18853656
    [Abstract] [Full Text] [Related]

  • 18. Homocysteinemia as an independent risk factor in the Chinese population at a high risk of coronary artery disease.
    Ni M, Zhang XH, Jiang SL, Zhang Y.
    Am J Cardiol; 2007 Aug 01; 100(3):455-8. PubMed ID: 17659928
    [Abstract] [Full Text] [Related]

  • 19. Diabetes exacerbates angiographic coronary lesion progression in subjects with metabolic syndrome independent of CRP levels.
    Liang KW, Lee WJ, Lee WL, Chen YT, Ting CT, Sheu WH.
    Clin Chim Acta; 2008 Feb 01; 388(1-2):41-5. PubMed ID: 17967444
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.